In preclinical research, what is the typical sequence?

In preclinical research, what is the typical sequence?

• A. Firstly cells, then tissues, then live animals
• B. Humans first
• C. Only computer models
• D. Only animals

Answer: (A)

Starting with simple, controlled models helps you learn how an intervention affects basic biology before adding complexity. Begin with cells studied in vitro to observe direct cellular effects, dosing, and potential toxicity in a clean context. If results look promising, move to tissues or organ cultures to see how the system behaves with more realistic cell–cell interactions, then advance to live animals to capture whole-body responses, pharmacokinetics, and systemic safety. This stepwise progression—cells first, then tissues, then live animals—fits how preclinical research builds understanding while minimizing risk and resource use. Jumping to humans or relying only on computer models or only on animals skips essential intermediate steps that inform safety and efficacy.

Starting with simple, controlled models helps you learn how an intervention affects basic biology before adding complexity. Begin with cells studied in vitro to observe direct cellular effects, dosing, and potential toxicity in a clean context. If results look promising, move to tissues or organ cultures to see how the system behaves with more realistic cell–cell interactions, then advance to live animals to capture whole-body responses, pharmacokinetics, and systemic safety. This stepwise progression—cells first, then tissues, then live animals—fits how preclinical research builds understanding while minimizing risk and resource use. Jumping to humans or relying only on computer models or only on animals skips essential intermediate steps that inform safety and efficacy.